News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current HNSBF market cap is 154.33M. The company's latest EPS is SEK -15.7906 and P/E is -0.19.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 3.36M | 6.1M | 33.88M | 154.53M | 134.09M |
| Operating Income | -357.6M | -425.08M | -539.58M | -576.12M | -791.16M |
| Net Income | -360.01M | -420.85M | -548.28M | -611.13M | -831.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 664.24M | 1.43B | 1.01B | 1.69B | 1.02B |
| Total Liabilities | 101.42M | 192.37M | 255.24M | 1.08B | 1.19B |
| Total Equity | 562.82M | 1.24B | 757.57M | 602.91M | -167.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -334.78M | -290.27M | -481.17M | -502.73M | -755.66M |
| Investing | 85.78M | 182.53M | -2.4M | 229.31M | -284k |
| Financing | -8.88M | 1.07B | -4.86M | 1.12B | -7.55M |
| Market Cap | 154.33M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 1.15 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | -0.92 |
| Dividend Yield | - |
| Shares Outstanding | 52.67M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -38.38% |
| 52 Week High | 4.755 |
| 52 Week Low | 2.257 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Hansa Medical AB (CE) |
| Address |
scheelevagen 22 lund 223 63 |
| Website | https://www.hansabiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
